Download PDF
Z Gastroenterol 2008; 46(3): 279-291
DOI: 10.1055/s-2007-963427
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Ernährungsfaktoren und Ernährungstherapie beim Reizdarmsyndrom - was ist valide?

Nutritional Factors and Nutritional Therapy for Irritable Bowel Syndrome - What is Worthwhile?A. Wächtershäuser1 , J. M. Stein2
  • 1Medizinische Klinik I - ZAFES (Direktor Prof. Dr. S. Zeuzem), Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main
  • 2Katharina-Kasper-Kliniken, Lehrkrankenhaus der Johann Wolfgang Goethe-Universität, Frankfurt am Main
Further Information

Publication History

Manuskript eingetroffen: 19.2.2007

Manuskript akzeptiert: 16.7.2007

Publication Date:
06 March 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Prävalenz von Reizdarmsyndrom (RDS) hat in den letzten 50 Jahren in den Ländern mit westlichen Verzehrsgewohnheiten zugenommen, 20 - 65 % der Patienten mit Reizdarmsyndrom sehen einen Zusammenhang zwischen Nahrungsbestandteilen und der Beschwerdesymptomatik. Die Daten zu Eliminationsdiäten und Provokationsversuchen sind jedoch widersprüchlich. Obwohl es Untersuchungen gibt, dass Ballaststoffe bei einigen Reizdarmpatienten helfen können, gibt es in der Literatur keine einheitlichen diätetischen Empfehlungen. Einige Studien belegen, dass Probiotika zu einer Minderung der Symptome beitragen können. Trotz verschiedener Arbeiten, die sich mit der Thematik beschäftigen, erscheint es schwierig, Ernährungsempfehlungen für Reizdarmpatienten zu formulieren; jedoch kann eine Ernährungsberatung durchaus wertvoll für die Patienten sein. Weitere prospektive Studien sind erforderlich, um den Einfluss von diätetischen Faktoren und Probiotika in diesem Zusammenhang zu evaluieren.

Abstract

The prevalence of irritable bowel syndrome (IBS) has increased over the last 50 years in countries where a Western-style diet has been prominent or introduced and 20 - 65 % of patients with irritable bowel syndrome (IBS) attribute their symptoms to something in food that activates an abnormal response. However, data from dietary elimination and re-challenge studies are inconclusive. Although investigations have shown that bran may be helpful in some patients, a complete review of the literature does not reveal conclusive evidence that a high fibre diet therapy is effective in IBS. From the limited reports on probiotics, there appears to be a trend to decreasing symptoms. Despite numerous reviews on this subject, it is very difficult to give general dietary advice to IBS patients, but dietary experts may have a positive role in managing such patients. It is clear that much more prospective research is needed to study both dietary factors and probiotics in these areas.

Schlüsselwörter

Reizdarmsyndrom - Ernährungstherapie - Fruktosemalabsorption - Laktoseintoleranz - Diät - Prä-/Probiotika - Gluten - Pfefferminzöl

Key words

irritable bowel syndrome - nutrition therapy - fructose malabsorption - lactose malabsorption - diet - pre-/probiotics - gluten - peppermint oil

Literatur

  • 1 Adam B, Liebregts T, Holtmann G. Das Reizdarmsyndrom.  Dtsch Med Wochenschr. 2005;  130 399-401
    Google Scholar
  • 2 Aller R, de Luis D A, Izaola O. et al . Efffects of a high-fiber diet on symptoms of irritable bowel syndrome : a randomized clinical trial.  Nutrition. 2004;  20 735-737
    Google Scholar
  • 3 Alpers D H. Diet and irritable bowel syndrome.  Curr Opin Gastroenterol. 2006;  22 136-139
    Google Scholar
  • 4 Arffmann S, Andersen J R, Hegnhoj J. et al . The effect of coarse wheat bran in the irritable bowel syndrome: a double blind crossover study.  Scand J Gastroenterol. 1985;  20 295-298
    Google Scholar
  • 5 Anderson D E, Nygren A. Four cases of long-standing diarrhea and colic pains cured by fructose-free diet - a pathogenetic discussion.  Acta Med Scand. 1978;  203 87-92
    Google Scholar
  • 6 Arthurs Y, Fielding J F. Double blind trial of ispaghula poloxamer in irritable bowel syndrome.  J Assoc Physicians India. 1984;  12 1041-1044
    Google Scholar
  • 7 Au A, Gupta A, Schembri P. et al . Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagons-like peptide 2.  Biochem J. 2002;  367 247-254
    Google Scholar
  • 8 Balsari A, Ceccarelli A, Dubin F. et al . The faecal microbial population in the irritable bowel syindrome.  Microbiologica. 1982;  5 185-194
    Google Scholar
  • 9 Barbara G, Stanghellini V, Brandi G. et al . Interactions between commensal bacteria and gut sensorimotor function in health and disease.  Am J Gastroenterol. 2005;  100 2560-2568
    Google Scholar
  • 10 Barbara G, Stanghellini V, De Giorgio R. et al . Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel sindrome.  Gastroenterology. 2004;  126 693-702
    Google Scholar
  • 11 Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.  J Pediatr. 2005;  147 197-201
    Google Scholar
  • 12 Bergonzelli G E, Blum S, Brüssow H. et al . Probiotics as a treatment strategy for gastrointestinal diseases?.  Digestion. 2005;  72 57-68
    Google Scholar
  • 13 Böhles H, Bargon J, Stein J. Ernährungstherapie von angeborenen Stoffwechsel- und Speichererkrankungen. Stein J, Jauch KW Praxishandbuch klinische Ernährung und Infusionstherapie Springer 2003: 652-676
    Google Scholar
  • 14 Bohmer C JM, Tuynman H. The clinical relevance of lactose malabsorption in irritable bowel syndrome.  Eur J Gastroenterol Hepatol. 1996;  8 1013-1016
    Google Scholar
  • 15 Born P, Zech J, Lehn H. et al . Colonic bacterial activity determines the symptoms in people with fructose-malabsorption.  Hepatogastroenterology. 1995;  42 778-785
    Google Scholar
  • 16 Brigidi P, Vitali B, Swennen E. et al . Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.  Res Microbiol. 2001;  152 735-741
    Google Scholar
  • 17 Caldarella P, Milano A, Laterza F. et al . Visceral sensitivity and symptoms in patients with constipation- or diarrea-predominant irritable bowel sindrome (IBS): effect of a low-fat intraduodenal infusion.  Am J Gastroenterol. 2005;  100 383-389
    Google Scholar
  • 18 Caldarella M P, Azpiroz F, Malagelada J R. Selective effects of nutrients on gut sensitivity and reflexes.  Gut. 2006; [Epub ahead of print]; 
    Google Scholar
  • 19 Camilleri M. Management of the irritable bowel syndrome.  Gastroenterology. 2001;  120 652-668
    Google Scholar
  • 20 Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy.  J Clin Gastroenterol. 2006;  40 264-269
    Google Scholar
  • 21 Cann P A, Read N W, Holdsworth C D. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?.  Gut. 1984;  25 168-173
    Google Scholar
  • 22 Castello A, Guma A, Sevilla L. et al . Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development an effect of diabetes.  Biochem J. 1995;  309 271-277
    Google Scholar
  • 23 Choi Y K, Johlin F C, Summers R W. et al . Fructose intolerance: An under-recognized problem.  Am J Gastroenterol. 2003;  98 1348-1353
    Google Scholar
  • 24 Cook I J, Irvine E J, Campbell D. et al . Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome: a controlles crossover study.  Gastroenterology. 1990;  98 66-72
    Google Scholar
  • 25 Cummings J H, Macfarlane G T. Gastrointestinal effects of prebiotics.  Br J Nutr. 2002;  87 (Suppl 2) S145-S151
    Google Scholar
  • 26 Dapoigny M, Stockbrugger R W, Azpiroz F. et al . Role of alimentation in irritable bowel syndrome.  Digestion. 2003;  67 225-233
    Google Scholar
  • 27 Dainese R, Galliani E A, DeLazzari F. et al . Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients.  Am J Gastroenterol. 1999;  94 1892-1897
    Google Scholar
  • 28 De Baptista G. Nutrients and dyspepsia: paradigms and reality.  Curr Opin Nutr Metab Care. 2005;  8 562-567
    Google Scholar
  • 29 Dear K L, Elia M, Hunter J O. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?.  Dig Dis Sci. 2005;  50 758-766
    Google Scholar
  • 30 Dingermann T, Loew D. Magen-Darm-Erkrankungen. Dingermann T, Loew D Phytopharmakologie - Experimentelle und klinische Pharmakologie pflanzlicher Arzneimittel Stuttgart; Wissenschaftliche Verlagsgesellschaft mbH 2003: 204-213
    Google Scholar
  • 31 Drossman D A, Camilieri M, Mayer E A. et al . AGA Technical review on irritable bowel syndrome.  Gastroenterology. 2002;  123 2108-2131
    Google Scholar
  • 32 Drossman D A. The functional gastrointestinal disorders an the Rome III process.  Gastroenterology. 2006;  130 1377-1390
    Google Scholar
  • 33 Dyer J, Wood I S, Palejwala A. et al . Expression of monosaccharide transporters in intestine of diabetic humans.  Am J Physiol. 2002;  282 G241-G248
    Google Scholar
  • 34 Enck P, Kremer A, Kuhlbusch R. et al . Prevalence of lactose malabsorption among patients with functional bowel disorders.  Z Gastroenterol. 1990;  28 239-234
    Google Scholar
  • 35 Fernandez-Banares F, Esteve-Pardo M, Leon de R. et al . Sugar malabsorption in functional bowel disease: clinical implications.  Am J Gastroenterol. 1993;  88 2044-2050
    Google Scholar
  • 36 Floch M H. Use of Diet and Probiotic Therapy in the irritable bowel syndrome. Analysis of the literature.  J Clin Gastroenterol. 2005;  39 S243-S246
    Google Scholar
  • 37 Fowlie S, Eastwood M, Prescott R. Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation.  J Psychosom Res. 1992;  36 175-180
    Google Scholar
  • 38 Francis C Y, Whorwell P J. Bran and irritable bowel syndrome: time for reappraisal.  Lancet. 1994;  344 39-40
    Google Scholar
  • 39 Freise J, Köhler S. Peppermint oil-caraway oil fixed combination in non-ulcer dyspepsia - comparison of the effects of enteric preparations.  Pharmazie. 1999;  54 210-215
    Google Scholar
  • 40 Gade J, Thorn P. Paraghurt for patients with irritable bowel syndrome. A controlled clinical investigation from general practice.  Scand J Prim Health Care. 1989;  7 23-26
    Google Scholar
  • 41 Garcia-Herrera J, Navarro M A, Marca M C. et al . The effect of tumor necrosis factor-alpha on D-fructose intestinal transport in rabbits.  Cytokine. 2004;  25 21-30
    Google Scholar
  • 42 Gibson P R, Shepherd S J. Personal view: food for thought - western lifestyle and susceptibility to crohn’s disease. The FODMAP hypothesis.  Aliment Pharmacol Ther. 2005;  21 1399-1409
    Google Scholar
  • 43 Gibson P R, Newnham E, Barrett J S. et al . Review article: fructose malabsorption and the bigger picture.  Aliment Pharmacol Ther. 2006;  25 349-363
    Google Scholar
  • 44 Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints.  Isr Med Assoc J. 2000;  2 583-587
    Google Scholar
  • 45 Golecha A C, Chadda V S, Chadda S. et al . Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double blind crossover Study).  J Assoc Physicians India. 1982;  30 353-355
    Google Scholar
  • 46 Gouyon F, Caillaud L, Carriere V. et al . Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice.  J Physiol. 2003;  552 823-832
    Google Scholar
  • 47 Grigoleit H G, Grigoleit P. Peppermint oil in irritable bowel syndrome.  Phytomedicine. 2005;  12 601-606
    Google Scholar
  • 48 Grigoleit H G, Grigoleit P. Gastrointestinal clinical pharmacology of peppermint oil.  Phytomedicine. 2005;  12 607-612
    Google Scholar
  • 49 Halpern G M, Prindiville T, Blankenburg M. et al . Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.  Am J Gastroenterol. 1996;  91 1579-1585
    Google Scholar
  • 50 Hoekstra J H, van Kempen A A, Bijl S B. et al . Fructose breath hydrogen tests.  Arch Dis Child. 1993;  68 136-138
    Google Scholar
  • 51 Hoekstra J H, Aker J H. Facilitating effect of amino acids on fructose and sorbitol absorption in children.  J Pediatr Gastroenterol Nutr. 1996;  23 118-124
    Google Scholar
  • 52 Holtmann van den G, Gschossmann J M, Buenger L. Effects of a fixed peppermint oil caraway oil combination (PCC) on symptoms and quality of life in functional dyspepsia.  Gastroenterology. 2000;  120 (Suppl) 36
    Google Scholar
  • 53 Holtmann G. IBS: a syndrome or many diseases?.  Best Pract Res Clin Gastroenterol. 2004;  18 (Suppl) 91-97
    Google Scholar
  • 54 Holtmeier W. Diagnosis of celiac disease.  Z Gastroenterol. 2005;  43 1243-1252
    Google Scholar
  • 55 Hotz J, Enck P, Goebell H. et al . : Konsensusbericht: Reizdarmsyndrom-Definition, Diagnosesicherung, Pathophysiologie und Therapiemöglichkeiten. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterol. 1999;  37 685-700
    Google Scholar
  • 56 Hussain Z, Quigley E M. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome.  Aliment Pharmacol Ther. 2006;  23 465-471
    Google Scholar
  • 57 Jain N K, Patel V P, Pitchumoni C S. Sorbitol intolerance in adults. Prevalence and pathogenesis on two continents.  J Clin Gastroenterol. 1987;  9 317-319
    Google Scholar
  • 58 Jalihal A, Kurian G. Ispaghula therapy in irritable bowel syndrome: improvement in overall well being related to reduction in bowel dissatisfaction.  J Gastroenterol Hepatol. 1990;  5 507-513
    Google Scholar
  • 59 Johlin F C, Panther M, Kraft N. A fructose restricted diet and dietary counselling in patients with dietary fructose intolerance demonstrates significant reduction in symptoms and an improvement in quality of life proportionate to the amount of fructose eliminated.  Gastroenterology. 2001;  120 A1374 (Abstract)
    Google Scholar
  • 60 Jones V A, McLaughlan P, Shorthouse M. et al . Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome.  Lancet. 1982;  20 (2) 1115-1117
    Google Scholar
  • 61 Jun D W, Lee O Y, Yoon L J. et al . Food intolerance and skin prick test in treated and untreated irritable bowel syndrome.  World J Gastroenterol. 2006;  21 2382-2387
    Google Scholar
  • 62 Kajander K, Korpela R. Clinical studies on alleviating the symptoms of irritable bowel syndrome.  Asia Pac J Clin Nutr. 2006;  15 576-580
    Google Scholar
  • 63 Karamanolis G, Tack J. Nutrition and motility disorders.  Best Pract Res Clin Gastroenterol. 2006;  20 485-505
    Google Scholar
  • 64 Keller J, Franke A, Storr M. et al . Clinically relevant breath tests in gastroenterological diagnostics - recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases.  Z Gastroenterol. 2005;  43 1071-1090
    Google Scholar
  • 65 Kellett G L, Brot-Laroche E. Apical GLUT2. A major pathway of intestinal sugar absorption.  Diabetes. 2005;  54 3056-3062
    Google Scholar
  • 66 Kim H J, VazquezRoque M I, Camilleri M. et al . A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel sindrome with bloating.  Neurogastroenterol Motil. 2005;  17 687-696
    Google Scholar
  • 67 Kishi K, Tanaka T, Igawa M. et al . Sucrase-isomaltase and hexose transporter gene expressions are coordinately enhanced by dietary fructose in rat jejunum.  J Nutr. 1999;  129 953-956
    Google Scholar
  • 68 Klauser A G, Volerholzer W A, Schindlbeck N E. et al . Functional diagnosic work-up in patients with irritable bowel syndrome.  Z Gastroenterol. 1996;  34 273-278
    Google Scholar
  • 69 Klein-Tebbe J, Lepp U, Niggemann B. et al . Nahrungsmittelallergie und -unverträglichkeit: Bewährte statt nicht evaluierte Diagnostik.  Deutsches Ärzteblatt. 2005;  27 A1965-A1969
    Google Scholar
  • 70 Kneepkens C M, Vonk R J, Fernandes J. Incomplete intestinal absorption of fructose.  Arch Dis Child. 1984;  59 735-738
    Google Scholar
  • 71 Koebnick C, Wagner I, Leitzmann P. et al . Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.  Can J Gastroenterol. 2003;  17 655-659
    Google Scholar
  • 72 Krammer H J, Schlieger F, Harder H. et al . Probiotics as therapeutic agents in irritable bowel syndrome.  Z Gastroenterol. 2005;  43 467-471
    Google Scholar
  • 73 Krammer H J, Kamper H, Bunau von R. et al . Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients.  Z Gastroenterol. 2006;  44 651-656
    Google Scholar
  • 74 Kruis W, Weinzierl M, Schussler P. et al . Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.  Digestion. 1986;  34 196-201
    Google Scholar
  • 75 Kumar A, Kumar N, Vij J C. et al . Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.  Gut. 1987;  28 150-155
    Google Scholar
  • 76 Kurdi P, Tanaka H, van Veen H W. et al . Cholic acid accumulation and its diminution by short-chain fatty acids in Bifidobacteria.  Microbiology. 2003;  149 2031-2037
    Google Scholar
  • 77 Ladas S D, Grammenos I, Tassios P S. et al . Coincidental malabsorption of lactose, fructose, and sorbitol ingested at low doses is not common in normal adults.  Dig Dis Sci. 2000;  45 2357-2362
    Google Scholar
  • 78 Lawal A, Kern M, Sidhu H. et al . Novel evidence for hypersensitivity of visceral sensory neural circuity in irritable bowel syndrome patients.  Gastroenterology. 2006;  130 26-33
    Google Scholar
  • 79 Layer P, Keller J. Das Reizdarmsyndrom - Pathogenese, Diagnostik und Therapie. Bremen; Uni-Med Verlag 2003: 75
    Google Scholar
  • 80 Lea R, Whorwell P J. The Role of Food Intolerance in Irritable Bowel Syndrome.  Gastroenterol Clin N Am. 2005;  34 247-255
    Google Scholar
  • 81 Ledochowski M, Widner B, Fuchs D. Fruktoseunverträglichkeit.  J Ernährungsmed. 2000;  3 10-14
    Google Scholar
  • 82 Ledochowski M, Murr C, Lass-Florl C. et al . Increased serum amylase and lipase in fructose malabsorbers.  Clin Chim Acta. 2001;  311 119-123
    Google Scholar
  • 83 Lin H C. Small intestinal bacterial overgrowth: A frame-work for understanding irritable bowel disease.  JAMA. 2004;  292 852-858
    Google Scholar
  • 84 Locke G R, Zinsmeister A R, Talley N J. et al . Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities.  Am J Gastroenterol. 2000;  95 157-165
    Google Scholar
  • 85 Longstreth G F, Fox D D, Youkeles L. et al . Psyllium therapy in the irritable bowel syndrome: a double blind trial.  Ann Intern Med. 1981;  95 53-56
    Google Scholar
  • 86 Longstreth G F, Thompson W G, Chey W D. et al . Functional bowel disorders.  Gastroenterology. 2006;  130 1480-1491
    Google Scholar
  • 87 Lucey M R, Clark M L, Lowndes J O. et al . Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.  Gut. 1987;  28 221-225
    Google Scholar
  • 88 Madisch A, Heydenreich C J, Wieland V. et al . Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.  Drug Res. 1999;  49 925-932
    Google Scholar
  • 89 Madsen J L, Linnet J, Rumessen J J. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers.  Dig Dis Sci. 2006;  51 147-153
    Google Scholar
  • 90 Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy.  J Allergy Clin Immunol. 1997;  99 179-185
    Google Scholar
  • 91 Malinen E, Rinttila T, Kajander K. et al . Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.  Am J Gastroenterol. 2005;  100 373-382
    Google Scholar
  • 92 Manning A P, Harvey R F, Heaton K W. Wheat fiber and irritable bowel syndrome: a controlled trial.  Lancet. 1977;  1 419-421
    Google Scholar
  • 93 Marks J, Carvou N J, Debnam E S. et al . Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximale tubule brush border membrane.  J Physiol. 2003;  553 137-145
    Google Scholar
  • 94 Matthews S B, Waud J P, Roberts A G. et al . Systemic lactose intolerance: a new perspective on an old problem.  Postgrad Med J. 2005;  81 167-173
    Google Scholar
  • 95 May B, Kuntz H D, Kieser M. et al . Efficacy of a fixed peppermint oil and caraway oil on gastruduodenal motility.  Phytother Res. 1996;  14 20-23
    Google Scholar
  • 96 May B, Köhler S, Schneider B. Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia.  Aliment Pharmacol Ther. 2000;  14 1671-1677
    Google Scholar
  • 97 Micklefield G, Greving I, May B. Effects of peppermint oil and caraway oil on gastrointestinal motility.  Phytother Res. 2000;  14 20-23
    Google Scholar
  • 98 Mishkin D, Sablauskas L, Yalovsky M. et al . Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison with lactose maldigestion/malabsorption.  Dig Dis Sci. 1997;  42 2591-2598
    Google Scholar
  • 99 Mönnikes H, Schmidtmann M, Voort. et al . Arzneimitteltherapie des Reizdarmsyndroms.  Internist. 2006;  47 1073-1083
    Google Scholar
  • 100 Molin C. Probiotics in foods not containing milk or millk constituents, with special reference to Lactobacillus plantarum 299v.  Am J Clin Nutr. 2001;  73 380S-385S
    Google Scholar
  • 101 Monsbakken K W, Vandvik P O, Farup P G. Perceived food intolerance in subjects with irritable bowel syndrome - etiology, prevalence and consequences.  Eur J Clin Nutr. 2006;  60 667-672
    Google Scholar
  • 102 Müller P, Meier C, Böhme H J. et al . Fructose breath hydrogen test - is it really a harmless diagnostic procedure?.  Dig Dis. 2003;  21 276-278
    Google Scholar
  • 103 Nelis G F, Vermeeren M A, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome.  Gastroenterology. 1990;  99 1016-1020
    Google Scholar
  • 104 Newcomer A D, McGill D B. Irritable bowel syndrome. Role of lactase deficiency.  Mayo Clin Proc. 1983;  58 339-341
    Google Scholar
  • 105 Niec A M, Frankum B, Talley N J. Are adverse food reactions linked to irritable bowel syndrome?.  Am J Gastroenterol. 1998;  93 2184-2190
    Google Scholar
  • 106 Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.  Eur J Gastroenterol Hepatol. 2001;  13 1143-1147
    Google Scholar
  • 107 Nigam P, Kapoor K K, Rastog C K. et al . Different therapeutic regimens in irritable bowel syndrome.  J Assoc Physicians India. 1984;  12 1041-1044
    Google Scholar
  • 108 Niv E, Naftali T, Hallak R. et al . The efficacy of Lactobacillus reuteri ATCC 55 730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study.  Clin Nutr. 2005;  24 925-931
    Google Scholar
  • 109 Nobaek S, Johansson M L, Molin G. et al . Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.  Am J Gastroenterol. 2000;  95 1231-1238
    Google Scholar
  • 110 Nucera G, Gabrielli M, Lupascu A. et al . : Abnormal breath test to lactose, fructose and sorbitol in irritable bowel sindrome may be explained by small intestinal bacterial overgrowth.  Aliment Pharmacol Ther. 2005;  21 1391-1395
    Google Scholar
  • 111 O’Mahony L, McCarthy J, Kelly P. et al . Lactobacilli and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.  Gastroenterology. 2005;  128 541-551
    Google Scholar
  • 112 O’Sullivan M A, O’Morain C A. Bacterial supplementation in the irritable bowel syndrome: a randomized double-blind placebo-controlled crossover study.  Dig Liver Dis. 2000;  32 294-301
    Google Scholar
  • 113 Park M I, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review.  Neurogastroenterol Motil. 2006;  18 595-607
    Google Scholar
  • 114 Parker T J, Woolner J T, Prevost A T. et al . Irritable bowel syndrome: is the search for lactose intolerance justified?.  Eur J Gastroenterol Hepatol. 2001;  13 219-225
    Google Scholar
  • 115 Parisi G, Bottona E, Carrara M. et al . Treatment effects of partially hydrolyzed guar gum on symptoms and qualità of life of patients with irritable bowel sindrome: a multicenter randomized open trial.  Dig Dis Sci. 2005;  50 1107-1112
    Google Scholar
  • 116 Parisi G C, Zilli M, Miani M P. et al . High-fiber diet supplementation in patients with irritable bowel sindrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).  Dig Dis Sci. 2002;  47 1697-1704
    Google Scholar
  • 117 Petitpierre M, Gumovski P, Girard J P. Irritable bowel syndrome and hypersensitivity to food.  Ann Allergy. 1985;  54 538-540
    Google Scholar
  • 118 Prior A, Whorwell P J. Double blind study of ispaghula in irritable bowel syndrome.  Gut. 1987;  28 1510-1513
    Google Scholar
  • 119 Quartero A O, Meineche-Schmidt V, Muris J. et al . Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.  The Cochrane Database of Systematic Reviews. 2005;  Issue 2. Art. No.: CD 003 460 DOI: 0.1002 / 14 651858.CD 003 460.pub2
    Google Scholar
  • 120 Quigley E. The use of probiotics in functional bowel disease.  Gastroenterol Clin N Ann. 2005;  34 533-545
    Google Scholar
  • 121 Ravich W J, Bayless T M, Thomas M. Fructose. Incomplete intestinal absorption in humans.  Gastroenterology. 1983;  84 26-29
    Google Scholar
  • 122 Ritchi J A, Truelove S C. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide and ispaghula husk.  BMJ. 1979;  1 376-378
    Google Scholar
  • 123 Ritchi J A, Truelove S C. Comparison of various treatments for irritable bowel syndrome.  BMJ. 1980;  281 1317-1319
    Google Scholar
  • 124 Riordan S M, Kim R. Bacterial overgrowth as a cause of irritable bowel syndrome.  Curr Opin Gastroenterol. 2006;  22 669-673
    Google Scholar
  • 125 Roberfroid M B, Delzenne N M. Dietary fructans.  Annu Rev Nutr. 1998;  18 117-143
    Google Scholar
  • 126 Romagnuolo J, Schiller D, Baily R J. Using breath tests wisely in a gastroenterology practice: An evidence-based review of indications and pitfalls in interpretation.  Am J Gastroenterol. 2002;  97 1113-1126
    Google Scholar
  • 127 Rumessen J J, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides.  Gut. 1986;  27 1161-1168
    Google Scholar
  • 128 Rumessen J J, Gudmand-Hoyer E. Malabsorption of fructose-sorbitol mixtures. Interactions causing abdominal distress.  Scand J Gastroenterol. 1987;  22 431-436
    Google Scholar
  • 129 Rumessen J J, Gudmand-Hoyer E. Functional bowel disease: Malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures.  Gastroenterology. 1988;  95 694-700
    Google Scholar
  • 130 Rumessen J J. Fructose and related food carbohydrates. Source, intake, absorption, and clinical implications.  Scand J Gastroenterol. 1992;  27 819-828
    Google Scholar
  • 131 Saggioro A. Probiotics in the treatment of irritable bowel syndrome.  J Clin Gastroenterol. 2004;  38 (Suppl) S104-106. Erratum in: J Clin Gastroenterol 2005; 39: 261
    Google Scholar
  • 132 Saito Y A, Locke G R, Weaver A L. et al . Diet and functional gastrointestinal disorders: a population-based case-control study.  Am J Gastroenterol. 2005;  100 2743-2748
    Google Scholar
  • 133 Sanders D S, Carter M J, Hurlstone D P. et al . Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.  Lancet. 2001;  358 1504-1508
    Google Scholar
  • 134 Schultz M, Linde H J, Lehn N. et al . Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers.  J Dairy Res. 2003;  70 165-173
    Google Scholar
  • 135 Sen S, Mullan M M, Parker T J. et al . : Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.  Dig Dis Sci. 2002;  47 2615-2620
    Google Scholar
  • 136 Shahbazkhani B, Forootan M, Merat S. et al . Coeliac disease presenting with symptoms of irritable bowel syndrome.  Aliment Pharmacol Ther. 2003;  18 231-235
    Google Scholar
  • 137 Shepherd E J, Helliwell P A, Mace O J. et al . Stress and glucocorticoid inhibit apical GLUT2-trafficking and intestinal glucose absorption in rat small intestine.  J Physiol. 2004;  560 281-290
    Google Scholar
  • 138 Shepherd S J, Gibson P R. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management.  J Am Diet Assoc. 2006;  106 1631-1639
    Google Scholar
  • 139 Simren M, Mansson A, Langkilde A M. et al . Food-related gastrointestinal symptoms in the irritable bowel syndrome.  Digestion. 2001;  63 108-115
    Google Scholar
  • 140 Skoog S M, Bharucha A E. Dietary fructose and gastrointestinal symptoms: a review.  Am J Gastroenterol. 2004;  99 2046-2050
    Google Scholar
  • 141 Snook J, Shepherd H A. Bran supplementation in the treatment of irritable bowel syndrome.  Aliment Pharmacol Ther. 1994;  8 511-514
    Google Scholar
  • 142 Soltoft J, Gudman-Hoyer E, Krag B. et al . A double blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome.  Lancet. 1976;  2 270-272
    Google Scholar
  • 143 Stein J, Jordan A. Ernährung bei Krankheiten des Gastrointestinaltraktes. Stein J, Jauch KW Praxishandbuch klinische Ernährung und Infusionstherapie Springer-Verlag Berlin, Heidelberg, New York 2003: 582-626
    Google Scholar
  • 144 Summers R W, Johlin F C. Fructose intolerance is due to rapid orocecal transit and not small bowel bacterial overgrowth.  Gastroenterology. 2001;  120 A1369 (Abstract)
    Google Scholar
  • 145 Symons P, Jones M P, Kellow J E. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol.  Scand J Gastroenterol. 1992;  27 940-944
    Google Scholar
  • 146 Terjung B, Lammert F. Laktoseintoleranz: Neue Aspekte eines alten Problems.  Dtsch Med Wochenschr. 2007;  132 271-275
    Google Scholar
  • 147 Thiesen A, Wild G E, Keelan M. et al . Locally and systemically active glucocorticosteroids modify intestinal absorption of sugars in rats.  J Appl Physiol. 2003;  94 583-590
    Google Scholar
  • 148 Tolliver B A, Jackson M S, Jackson K L. et al . Does lactose maldigestion really play a role in the irritable bowel?.  J Clin Gastroenterol. 1996;  23 15-17
    Google Scholar
  • 149 Torii A, Toda G. Management of Irritable Bowel Syndrome.  Int Med. 2004;  43 353-359
    Google Scholar
  • 150 Toskes P P, Connery K L, Ritchey T W. Calcium oplycarbophil compared with placebo in the irritable bowel syndrome.  Aliment Pharmacol Ther. 1993;  7 87-92
    Google Scholar
  • 151 Truswell A S, Seach J M, Thorburn A W. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose.  Am J Clin Nutr. 1988;  48 1424-1430
    Google Scholar
  • 152 Vanderhoof J A, Young R J. Use of prebiotics in childhood gastrointestinal disorders.  J Pediatr Gastroenterol Nutr. 1998;  27 323-332
    Google Scholar
  • 153 Verdu E F, Collins S M. Irritable bowel syndrome and probiotics: from rationale to clinical use.  Curr Opin Gastroenterol. 2005;  21 697-701
    Google Scholar
  • 154 Vernia P, Marinaro V, Argnani F. et al . Self-reported milk intolerance in irritable bowel syndrome: what should we believe?.  Clin Nutr. 2004;  23 996-1000
    Google Scholar
  • 155 Vesa T H, Seppo L M, Marteau P R. et al . Role of irritable bowel syndrome in subjective lactose intolerance.  Am J Clin Nutr. 1998;  67 71 071-71 075
    Google Scholar
  • 156 Villagrasa M, Boix J, Humbert P. et al . Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome.  Ital J Gastroenterol. 1991;  23 (Suppl) 67-70
    Google Scholar
  • 157 Wahnschaffe U, Ullrich R, Riecken E O. et al . Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.  Gastroenterology. 2001;  121 1329-1338
    Google Scholar
  • 158 Walker J, Jijon H B, Diaz H. et al . 5-Aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.  Biochem J. 2005;  385 485-491
    Google Scholar
  • 159 Zar S, Kumar D, Benson M J. Food hypersensitivity and irritable bowel syndrome.  Aliment Pharmacol Ther. 2001;  15 439-449
    Google Scholar
  • 160 Zar S, Benson M J, Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome.  Am J Gastroenterol. 2005;  100 1550-1557
    Google Scholar
  • 161 Zuckerman M J. The role of fiber in the treatment of irritable bowel syndrome.  J Clin Gastroenterol. 2006;  40 104-108
    Google Scholar

Prof. Jürgen M. Stein

Katharina-Kasper-Kliniken

Ginnheimer Straße 3-5

60487 Frankfurt

Phone: ++ 49/69/79 39 21 19

Fax: ++ 49/69/79 39 26 6

Email: j.stein@em.uni-frankfurt.de

      >